Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Front Microbiol ; 14: 1282257, 2023.
Article in English | MEDLINE | ID: mdl-37886075

ABSTRACT

Background: African animal trypanosomiasis hinders sustainable livestock productivity in sub-Saharan Africa. About 17 million infected cattle are treated with trypanocides annually but most of the drugs are associated with drawbacks, necessitating the search for a promising chemotherapeutic agent. Objectives: In this study, the effects of ß-sitosterol on Trypanosoma congolense infection were investigated along with its effect on the trans-sialidase gene expressions. Results: Oral treatment with ß-sitosterol at 15 and 30 mg/kg body weight (BW) for 14 days significantly (p < 0.05) reduced parasitemia and ameliorated the parasite-induced anemia. Also, the parasite-induced increase in serum urea level and renal histopathological damage scores in addition to renal hypertrophy was significantly (p < 0.05) reverted following treatment with 30 mg/kg BW ß-sitosterol. The compound also significantly (p < 0.05) down-regulated the expression of TconTS1 but not TconTS2, TconTS3, and TconTS4. Correlation analysis between free serum sialic acid with the TconTS1 and TconTS2 gene variants revealed negative correlations in the ß-sitosterol-treated groups although they were non-significant (p > 0.05) in the group treated with 15 mg/kg BW ß-sitosterol. Similarly, a non-significant negative (p > 0.05) correlation between the biomolecule and the TconTS3 and TconTS4 gene variants was observed in the ß-sitosterol-treated groups while positive correlations were observed in the infected untreated control group. Conclusion: The observed effect of ß-sitosterol on T. congolense infection could make the compound a possible template for the design of novel trypanocides.

2.
Chem Biol Drug Des ; 99(6): 908-922, 2022 06.
Article in English | MEDLINE | ID: mdl-35353953

ABSTRACT

Trypanosoma congolense is a pathogenic African animal trypanosome species causing devastating conditions leading to death of an infected host. The drawbacks of the existing trypanocidal drugs have led to the search for new drug candidates. In this study, ß-ionone at 15 and 30 mg/kg body weight (BW) was orally administered to T. congolense infected rats for 14 days followed by an assessment of anemia, organ damages, and the expression of T. congolense trans-sialidase gene variants. A significant decrease in parasitemia (p < .05) was observed in the animals treated with 15 mg/kg BW ß-ionone besides increased animal survival rate. A trypanosome-induced decrease in packed cell volume (PCV) and histopathological changes across tissues was significantly (p < .05) ameliorated following treatment with both doses of ß-ionone. This is in addition to reversing the parasite-induced upsurge in free serum sialic acid (FSA) and expression of T. congolense trans-sialidase gene variants (TconTS1, TconTS3, and TconTS4). Correlation analysis revealed a positive correlation (p > .05) between FSA with the TconTS gene expressions. In addition, the compound inhibited partially purified T. congolense sialidase and phospholipase A2 via mixed inhibition pattern with inhibition binding constants of 25.325 and 4.550 µM, respectively, while molecular docking predicted binding energies of -5.6 kcal/mol for both enzymes. In conclusion, treatment with ß-ionone suppressed T. congolense proliferation and protected the animals against some of the parasite-induced pathologies whilst the effect on anemia development might be due to inhibition of sialidase and PLA2 activities as well as the expression levels of TconTS3 and TconTS4.


Subject(s)
Anemia , Norisoprenoids , Trypanosoma congolense , Trypanosomiasis, African , Anemia/drug therapy , Anemia/parasitology , Animals , Cell Proliferation , Gene Expression , Glycoproteins , Molecular Docking Simulation , Neuraminidase , Norisoprenoids/pharmacology , Phospholipases A2/genetics , Rats , Trypanosoma congolense/genetics , Trypanosomiasis, African/drug therapy , Trypanosomiasis, African/parasitology
3.
Molecules ; 27(2)2022 Jan 12.
Article in English | MEDLINE | ID: mdl-35056785

ABSTRACT

Sub-Saharan Africa is profoundly challenged with African Animal Trypanosomiasis and the available trypanocides are faced with drawbacks, necessitating the search for novel agents. Herein, the chemotherapeutic potential of phloroglucinol on T. congolense infection and its inhibitory effects on the partially purified T. congolense sialidase and phospholipase A2 (PLA2) were investigated. Treatment with phloroglucinol for 14 days significantly (p < 0.05) suppressed T. congolense proliferation, increased animal survival and ameliorated anemia induced by the parasite. Using biochemical and histopathological analyses, phloroglucinol was found to prevent renal damages and splenomegaly, besides its protection against T. congolense-associated increase in free serum sialic acids in infected animals. Moreover, the compound inhibited bloodstream T. congolense sialidase via mixed inhibition pattern with inhibition binding constant (Ki) of 0.181 µM, but a very low uncompetitive inhibitory effects against PLA2 (Ki > 9000 µM) was recorded. Molecular docking studies revealed binding energies of -4.9 and -5.3 kcal/mol between phloroglucinol with modeled sialidase and PLA2 respectively, while a 50 ns molecular dynamics simulation using GROMACS revealed the sialidase-phloroglucinol complex to be more compact and stable with higher free binding energy (-67.84 ± 0.50 kJ/mol) than PLA2-phloroglucinol complex (-77.17 ± 0.52 kJ/mol), based on MM-PBSA analysis. The sialidase-phloroglucinol complex had a single hydrogen bond interaction with Ser453 while none was observed for the PLA2-phloroglucinol complex. In conclusion, phloroglucinol showed moderate trypanostatic activity with great potential in ameliorating some of the parasite-induced pathologies and its anti-anemic effects might be linked to inhibition of sialidase rather than PLA2.


Subject(s)
Phloroglucinol/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma congolense/drug effects , Trypanosomiasis, African/drug therapy , Anemia/complications , Anemia/drug therapy , Animals , Female , Kidney/drug effects , Kidney/parasitology , Kidney/pathology , Liver/drug effects , Liver/parasitology , Liver/pathology , Male , Molecular Docking Simulation , Molecular Dynamics Simulation , Neuraminidase/antagonists & inhibitors , Neuraminidase/chemistry , Organ Size/drug effects , Phloroglucinol/chemistry , Phloroglucinol/therapeutic use , Phospholipases A2/chemistry , Phospholipases A2/metabolism , Rats, Wistar , Survival Analysis , Trypanocidal Agents/chemistry , Trypanocidal Agents/therapeutic use , Trypanosoma congolense/parasitology , Trypanosomiasis, African/blood , Trypanosomiasis, African/complications , Trypanosomiasis, African/parasitology
4.
High Blood Press Cardiovasc Prev ; 28(3): 291-300, 2021 May.
Article in English | MEDLINE | ID: mdl-33826116

ABSTRACT

INTRODUCTION: Most available drugs used for management of hypertension have presented a plethora of challenges which genuinely called for development of therapies from natural sources. AIM: This study investigated the effect of methanol extract of Adansonia digitata fruit (MEADF) pulp on NG-nitro-L-arginine methyl ester (L-NAME) induced hypertension in rats. METHODS: Fourty eight (48) wistar rats divided into six (6) groups (eight rats each) were employed. The induction of hypertension was achieved using L-NAME (40mg//kg body weight) by oral gavages. The induced rats were treated with MEADF pulp (200 and 400 mg/kg body weight) and Ramipril (10 mg/kg) and the remaining three groups serve as control. Serum haemodynamic and biochemical modifiable parameters were determined using standard assay procedures RESULTS: Administration of MEADF to the rats exerted a dose-dependent lowering effect on the elevated systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate towards the normal physiological threshold. At 400 mg/kg of MEADF, there was significant (p < 0.05) reduction in serum lipid profile and biomarkers associated with endothelial dysfunction [angiotensin converting enzyme (ACE) activity], inflammation (C-reactive protein and interleukin-1ß), oxidative stress (malondialdehyde) and cardiac injury (creatine kinase-MB and lactate dehydrogenase activities). However, serum concentrations of nitric oxide, high density lipoprotein cholesterol, total bilirubin and albumin were not significantly (p < 0.05) different from those found in normal control group. CONCLUSION: This study therefore demonstrates that MEADF possesses an in vivo ACE inhibitory activity, hypotensive potential and the ability to avert further degeneration of biochemical and physiological upsets associated with L-NAME induced hypertension.


Subject(s)
Adansonia/chemistry , Antihypertensive Agents/therapeutic use , Hypertension/drug therapy , Plant Extracts/therapeutic use , Animals , Antihypertensive Agents/chemistry , Blood Pressure/drug effects , Female , Fruit/chemistry , Hypertension/chemically induced , Hypertension/physiopathology , Male , Methanol , NG-Nitroarginine Methyl Ester , Plant Extracts/chemistry , Rats , Rats, Wistar
5.
Glycoconj J ; 38(1): 129-134, 2021 02.
Article in English | MEDLINE | ID: mdl-33608771

ABSTRACT

Sialic acid and its associated metabolic enzymes have emerged as important components of the pathophysiology of type 2 diabetes (T2D). There is an elevation in the serum concentration of sialic acid in humans and animals with T2D. The present study investigated the modulation of mRNA expression level of UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE) and neuraminidase 1 (NEU1) genes in some organs of type 2 diabetic rats. T2D was induced using fructose-streptozotocin model and eight weeks after the induction of diabetes, sialic acid was assayed in the blood and organs (adipose tissue, brain, colon, kidney, liver, pancreas, skeletal muscle and spleen) followed by quantification of mRNA expression level of GNE and NEU1 genes by qPCR. The results showed a significant (P < 0.05) increase in sialic acid level in the serum and all the afore-mentioned organs investigated except in the adipose tissue and skeletal muscle of the diabetic rats compared the normal control. The expression GNE gene was only increased in the pancreas (1.8-fold) of the diabetic rats while there was a decrease in the expression of the gene in the colon. In contrast, the expression of NEU1 gene was increased in the spleen (3.5-fold), brain (2.2-fold), liver (1.9-fold), colon (1.5-fold) and kidney of the diabetic rats. It was concluded that the elevated level of sialic acid in the organs of diabetic rats, except the pancreas, might not be due to increased endogenous synthesis of sialic acid.


Subject(s)
Diabetes Mellitus, Type 2/enzymology , Multienzyme Complexes/genetics , Animals , Brain/enzymology , Colon/enzymology , Diabetes Mellitus, Experimental/enzymology , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Type 2/genetics , Gene Expression Regulation, Enzymologic , Liver/enzymology , N-Acetylneuraminic Acid/blood , N-Acetylneuraminic Acid/metabolism , Neuraminidase/genetics , Pancreas/enzymology , Rats, Wistar , Real-Time Polymerase Chain Reaction , Spleen/enzymology
6.
J Basic Clin Physiol Pharmacol ; 32(6): 1121-1130, 2020 Dec 14.
Article in English | MEDLINE | ID: mdl-34898137

ABSTRACT

OBJECTIVES: Snakebite envenoming is an important public health problem that threatens the lives of healthy individuals especially in many tropical countries like Nigeria. Antivenins, the only efficient approach for snakebite envenoming, are limited in their efficacy in the neutralization of local tissue damage. Snake venom phospholipase A2 (PLA2), protease, hyaluronidase and l-amino acid oxidase (LAAO) are the major hydrolytic enzymes involve in local tissue damage. Therefore, this study evaluates the inhibitory effect of kolaviron (KV) against Naja n. nigricollis (NNN) snake venom hydrolytic enzymes involved in local tissue damage. METHODS: Kolaviron was evaluated for its ability to inhibit the hydrolytic enzyme activities of NNN venom phospholipase A2 (PLA2), protease, hyaluronidase and l-amino acid oxidase (LAAO). Present study also deals with the neutralization of NNN venom enzyme(s) induced complications such as myotoxic, edemic, hemolytic and procoagulant effects. RESULTS: Kolaviron inhibited the PLA2, protease, hyaluronidase and LAAO enzyme activities of NNN venom in a dose-dependent manner. Furthermore, myotoxic, edemic, hemolytic and procoagulant effects induced by NNN venom enzyme were neutralized significantly (p<0.05) when different doses of KV were pre-incubated with venom before assays. CONCLUSIONS: These findings clearly present kolaviron as a potent inhibitor against NNN venom hydrolytic enzymes involved in local tissue damage and may act by either forming an inhibitor-enzyme complex that restricts the substrate availability to the enzyme or direct binding to the enzyme active site that affects the enzyme activity thereby mitigating venom-induced toxicity.


Subject(s)
Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Snake Bites , Snake Venoms , Humans , Hyaluronoglucosaminidase/antagonists & inhibitors , L-Amino Acid Oxidase/antagonists & inhibitors , Peptide Hydrolases , Phospholipases/antagonists & inhibitors , Polyesters , Protease Inhibitors , Snake Bites/drug therapy , Snake Venoms/toxicity
7.
J Med Food ; 15(1): 83-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21877945

ABSTRACT

The methanolic extract of Grewia mollis leaves was evaluated in vivo for its antioxidant and hepatoprotective properties. Oxidative stress was induced in rats by administering carbon tetrachloride (CCl(4)) intraperitoneally at a dose of 0.6 mL/kg, whereas the crude plant extract and standard antioxidant (vitamin E) were administered at a dose of 5 mg/kg and 50 mg/kg, respectively. The effect of G. mollis crude extracts and vitamin E on malondialdehyde (MDA) and liver function parameters such as protein, bilirubin, aspartate aminotransferase, and alanine aminotransferase were measured spectrophotometrically. The methanolic extract of G. mollis leaves and vitamin E showed a significant (P<.05) hepatoprotective potential by lowering the serum levels of bilirubin, aspartate aminotransferase, and alanine aminotransferase and decreasing MDA levels in rats pretreated or post-treated with CCl(4). Based on these results, it is concluded that G. mollis leaves contain potent antioxidant compounds that could offer protection against hepatotoxicity as well as ameliorate preexisting liver damage and oxidative stress conditions.


Subject(s)
Antioxidants/therapeutic use , Chemical and Drug Induced Liver Injury/drug therapy , Grewia , Liver/drug effects , Oxidative Stress/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Alanine Transaminase/blood , Animals , Antioxidants/pharmacology , Aspartate Aminotransferases/blood , Bilirubin/blood , Carbon Tetrachloride , Chemical and Drug Induced Liver Injury/blood , Liver/metabolism , Male , Malondialdehyde/blood , Plant Extracts/pharmacology , Plant Leaves , Rats , Vitamin E/pharmacology , Vitamin E/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...